Potentially tough road for BMS as immuno-oncology pricing war looms

May 5, 2021

GSK’s Asthma Drug Meets Primary Endpoint in Phase 3 Trial

September 10, 2024

Dupixent may become the first biologic treatment for COPD, according to late-stage trial data

March 29, 2023

Must Read

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

May 12, 2026

Can AI Reduce Drug Development Costs Without Increasing Risk?

May 12, 2026

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

May 12, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

Entrada Therapeutics Reports 2.36% Dystrophin Increase in Early DMD Trial Data

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Can AI Reduce Drug Development Costs Without Increasing Risk?

Top 10 Skills Every Life Sciences Professional Needs in 2026

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

Commercial

Pfizer and AstraZeneca unveil plans for almost $1B of new investments in France

Editor Picks

Potentially tough road for BMS as immuno-oncology pricing war looms

GSK’s Asthma Drug Meets Primary Endpoint in Phase 3 Trial

Dupixent may become the first biologic treatment for COPD, according to late-stage trial data

Must Read

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Can AI Reduce Drug Development Costs Without Increasing Risk?

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

Hot Topics

About Us

Follow Us